Navigation Links
NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
Date:9/17/2007

osis. In addition to working with Dr. Tabas on macrophage death pathways, Dr. Tall will work with Dr. Accili to investigate pathways involved in production of lipoproteins, such as very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL, often called bad cholesterol), in insulinresistant states. This will offer clues as to how high atherogenic lipoprotein levels contribute to heart disease in people with diabetes.

Dr. Domenico Accili s research is focused on the pathogenesis of insulin action and resistance and its role in type 2 diabetes. He plans to use new mouse models to investigate potentially pro-atherogenic or plaque-causing insulin actions in the liver and macrophages as part of this NIH grant. Dr. Accilis lab has recently shown that insulin action in liver, brain and beta cells is sufficient to confer insulin sensitivity onto the whole organism and protect against the development of diabetes in mice.

In addition, the lead investigators will call upon the biostatistical and mouse modeling expertise of Carrie L. Welch, Ph.D., associate research scientist, and Rajasekhar Ramakrishnan, Sc.D., research scientist and acting director of the division of biomathematics, to help with the design and analysis of mouse phenotype data and microarray experiments.


'/>"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...alif.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthca...helpingHispanic-Americanseniorsunderstandthebasics...dtotakeafreeZumba®Goldclass,aLatin-infusedfit...mbia,rumba,andtango. ,, UnitedHealthcarewilloff...bleandengagedwhenlearningabouttheirhealthcareoptio...
(Date:11/24/2009)...if.,Nov.24/PRNewswire/--Bionorica,aninternationalc...announcedtodaytheavailabilityofneweducationalresou...health.Atipsheeton"StayingNaturallyHealthyduringth...isnowavailableonthecompany,swebsiteat www.bionoric...reesubscriptiontotheNaturalMomstipsheets,withconte...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--HealthSouthCorporat...eBankofAmericaMerrillLynch2009CreditConferenceinNe...esidentandTreasurerEdFaywillbespeakingonThursday,D...tliveandwillbeavailableat http://investor.healthso...ealthSouth ,, HealthSouthisthenation,slargestp...
(Date:11/24/2009)...nt may help ward off peripheral artery disease, r...lthDay News) -- Among people aged 75 and older, th... heart attacks, stroke or death, a new study finds...bal remedy might help prevent the leg-circulation ...r. , Ginkgo contains nutrients called flavonoid...
(Date:11/24/2009)...ng improves heart prospects, but cancer risk remai... -- A new study offers yet more proof that smoking...se and cancer. , Researchers followed 12,152 Am...rs smokers and nonsmokers for three years. During ...kely to die of cancer, 2.26 times more likely to d...
Breaking Medicine News(10 mins):Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Smokers Double Their Risk for Heart Disease 2
...d in October near Danube Delta, Romania. But now n...ently. // The bird flu disaster is slowly creep...delta is a largest wetland in Europe and is an imp... bird flu. Bird flu is caused by the deadly st...
...troduced by TI Cycles India to make cycling more p...s bike can be split into two, and re-fixed after b... the cycle can be done in a matter of minutes. Two...ner cycle (Foldman) can be folded in three steps a...
... the motor symptoms of patients who suffer from Pa...the human retina, according to a study conducted b...uffer from the neurodegenerative disorder require ...yskinesias and motor fluctuations in the long run,...
...ls fear that the explosion will cause severe respi...ients.// The explosion ejected black thick smo...ave already prepared themselves to take in patient...ration due to oxygen level reduction in the brain....
...n be launched in Jharkhand for poor people in the ... will begin operating from January next year. ...obile hospitals with expert doctors will cover rur...ting machines and people can avail themselves of t...
... in the US and Canada are looking to India to proc...rders.// "Our consortium is trying to network...t and devices in India," John Remmers, a pioneer i...s the father of sleep medicine, and his associate ...
Other Medicine News:Health News:TI Cycles Introduces Foldman 2Health News:Cheap Indian devices sought to treat sleep disorder 2
(Date:11/24/2009)...,, BEIJING,Nov.24/PRNewswire-Asia-FirstCall/-...("Lotus"orthe"Company")agrowingdeveloperand,produc...harmaceutical,productsinthePeople,sRepublicChina,t...mberoftheBeijingpharmaceuticaldelegation. ,, ...ConventionCenter,Chengdu ,, TheBeijingdelegat...
(Date:11/24/2009)...,, WARSAW,Ind.,Nov.24/PRNewswire-FirstCall/--...dayitwillbeparticipatinginthe21stAnnualPiperJaffra...,2009,at8:00a.m.EasternTime. ,, Alivewebcastoft...tionswebsiteat http://investor.zimmer.com .Thewebc...,, AbouttheCompany ,, Foundedin1927andhead...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Ore...armaceuticalcompanyfocusedonthetreatmentofobesity,...CommitteeoftheCompany,sBoardofDirectorsgrantedanin...stocktoPrestonKlassen,M.D.,itsnewlyappointedHeadof...tendedtobeanincentivestockoptiontotheextentpermitt...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 1Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in 24160 000 Debt Collection Case 8957 3Fruit fly steps in to fight human disease 12735 1Fruit fly steps in to fight human disease 12735 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 1HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 3
...al Results Expected in Q3 2008, Conference Call t...tern Time, MOUNT...Inc. (Nasdaq: ALXA ) announced today that it has ... trial with AZ-004 (Staccato(R),loxapine). AZ-004 ... for,the treatment of acute agitation in patients ...
...Mass., June 9 Peptimmune, Inc., a privately,held ...sults from its,PI-2301 peptide copolymer program a... and at FOCIS 2008 in Boston, MA. The Company pres..., first-in-man study involving,healthy, male adult...ond-generation peptide copolymer PI-2301. This stu...
Other Medicine Technology:Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 2Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 3
Human Ferritin
CEA Kits
Quantaphase II RBC Folate Reagent Pack
Quantaphase II B12/Folate RIA
Medicine Products: